Evaluation of the Safety and the Tolerability of Durvalumab Plus Tremelimumab Combined With FOLFOX in mCRC
Clinical trial NCT03202758 · COMPLETED
Trial details
- NCT number
- NCT03202758
- Sponsor
- Centre Georges Francois Leclerc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-29
- Primary completion
- 2023-01-09
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.